Table A4.
Log-Rank Test on OS for BCLC Stages Split by VEGF Level*
| BCLC Stage | Patients (No.) | Events (No.) | Median OS (months) | 95% CI | P |
|---|---|---|---|---|---|
| 0 | NA | ||||
| All patients | 21 | 7 | 49.08 | 33.99 to NA | |
| VEGF level | |||||
| 0 | 21 | 7 | 49.08 | 33.99 to NA | |
| 1 | 0 | 0 | NA | ||
| A | .5974 | ||||
| All patients | 28 | 12 | 40.67 | 27.09 to NA | |
| VEGF level | |||||
| 0 | 24 | 11 | 40.67 | 27.09 to NA | |
| 1 | 4 | 1 | NA | 9.60 to NA | |
| B | .4007 | ||||
| All patients | 29 | 23 | 22.68 | 16.14 to 28.64 | |
| VEGF level | |||||
| 0 | 24 | 18 | 23.57 | 16.67 to 29.26 | |
| 1 | 5 | 5 | 13.22 | 12.69 to NA | |
| C | .105 | ||||
| All patients | 189 | 156 | 11.15 | 8.58 to 13.61 | |
| VEGF level | |||||
| 0 | 152 | 125 | 11.7 | 8.98 to 15.06 | |
| 1 | 37 | 31 | 9.11 | 4.04 to 17.75 | |
| D | .9357 | ||||
| All patients | 21 | 19 | 2.93 | 2.14 to 9.14 | |
| VEGF level | |||||
| 0 | 11 | 10 | 5.03 | 1.25 to NA | |
| 1 | 10 | 9 | 2.43 | 1.51 to NA |
Abbreviations: BCLC, Barcelona Clinic Liver Cancer; NA, not applicable; OS, overall survival; VEGF, vascular endothelial growth factor.
*
VEGF level: 0 if VEGF ≤ 450 pg/mL; 1 if VEGF > 450 pg/mL.